Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 28, 2017
Tumor suppressor miR-29c regulates radioresistance in lung cancer cellsElena Arechaga-Ocampo, Cesar Lopez-Camarillo, Nicolas Villegas-Sepulveda, et al.
Nature Medicine|October 25, 2018
Publisher Correction: Neuromodulation of lumbosacral spinal networks enables independent stepping after complete paraplegiaMegan L Gill, Peter J Grahn, Jonathan S Calvert, et al.
Journal of Global Oncology|September 23, 2018
Frequency of BRAF V600E Mutation in the Mexican Population of Patients With Metastatic MelanomaErika Ruiz-Garcia, Juan A Matus-Santos, Jorge Alberto Guadarrama-Orozco, et al.
Frontiers in Immunology|July 4, 2024
Immunogenicity of PvCyRPA, PvCelTOS and Pvs25 chimeric recombinant protein of <i>Plasmodium vivax</i> in murine modelAda da Silva Matos, Isabela Ferreira Soares, Rodrigo Nunes Rodrigues-da-Silva, et al.
Mayo Clinic Proceedings|April 8, 2017
Enabling Task-Specific Volitional Motor Functions via Spinal Cord Neuromodulation in a Human With ParaplegiaPeter J Grahn, Igor A Lavrov, Dimitry G Sayenko, et al.
Nature Communications|February 17, 2019
A functional subset of CD8<sup>+</sup> T cells during chronic exhaustion is defined by SIRPα expressionLara M Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factorsSeodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
Nature Communications|January 9, 2016
Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cellsSabine Klawitter, Nina V Fuchs, Kyle R Upton, et al.
Nature Communications|December 21, 2018
Author Correction: Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cellsSabine Klawitter, Nina V Fuchs, Kyle R Upton, et al.
Pageof 9